Mr Michael Jenkinson MB ChB, PhD, FRCSEd (Neuro.Surg)

Clinical Senior Lecturer in Neurosurgery Molecular and Clinical Pharmacology


    Personal Statement

    Michael D. Jenkinson qualified from the University of Liverpool in 1998. He undertook neurosurgical training at The Walton Centre, Liverpool between 2001 and 2010, which included three years as a clinical research fellow culminating in a PhD in Neuroscience (Imaging and Biology of Oligodendroglial Tumours). He learnt awake craniotomy and brain mapping techniques in Liverpool, San Francisco and Montpellier. He was appointed as a Consultant Neurosurgeon and at The Walton Centre in March 2010. He has recently joined the University of Liverpool as a Clinical Senior Lecturer in Neurosurgery.

    He sub-specialises in neurosurgical oncology for intrinsic brain tumours including awake craniotomy and intra-operative brain mapping for low grade glioma, midline and endoscopic approaches to intraventricular and deep intrinsic tumours and stereotactic radiosurgery.

    He sits in the NCRI brain tumour clinical studies group and the Imaging and Technology subgroup, as well as being a member of the Society of British Neurological Surgeons academic committee, and associate editor of the British Journal of Neurosurgery. He is a founding member of the British-Irish Meningioma Society (BIMS).

    His research interests include imaging and biology of gliomas, cerebral metastases and meningoma, clinical trials of new therapeutics for gliomas and stereotactic radiosurgery for brain metastasis. He is the recipient of grants for basic science and clinical research from the MRC and NIHR. This includes £1.36m from the NIHR to run the international, multi-centre ROAM trial (Radiation versus Observation following surgical resection of Atypical Meningioma). The trial is open to recruitment. He is also the co-chief investigator on the NIHR funded, multi-centre national BASICS trial (The British Antibiotic and Silver Impregnated Catheters for ventriculoperitoneal Shunts randomized controlled trial).
    He is also leading a pilot study to investigate the use of Ketogenic diet for patients with glioblastoma. The KEATING study is open to recruitment for patients being treated at The Walton Centre, Liverpool.

    He recently appeared in the UK Channel 5 series ‘Brain Hospital: Saving Lives’, which raised public awareness of the challenges faced by brain tumour patients and their families and friends.

    Personal Distinctions

    • Radiation versus Observation following surgical resection of Atypical Meningioma: an international multi-centre randomised controlled trial (Keynote Speech, World Federation of Neurosurgical Societies Interim meeting, Rome 2015)
    • Atypical Meningioma: observe, resect, irradiate? (Invitation to Speak, Royal College of Radiologists Neuro-oncology update meeting, Leeds 2015)
    • Clinical Evidence and interdisciplinary practice guide for brain metastases. (Invitation to Speak, BrainLAB symposium at European Society for Radiotherapy and Oncology, Barcelona 2015)
    • Medical documentaries: are they worth it? (Invitation to Speak, British Neuro-Oncology Society, Nottingham, 2015)
    • Techniques for maximising tumour resection in glioblastoma. (Invitation to Speak, European Photonics Industry Consortium, Rotterdam, Netherlands 2014)
    • Atypical meningioma: is radiotherapy necessary? (Invitation to Speak, European Association of Neurological Surgeons, Prague. 2014)
    • Radiosurgery for metastases and the status of whole brain radiotherapy. (Invitation to Speak, 3rd European Novalis Radiosurgery Symposium, Freiburg, Germany 2011)
    • Phase II trial of intra-tumoral BCNU in glioblastoma (Invitation to Speak, European Association of Neurosurgeons, Greece 2006)
    • Clinical Research Fellowship (Competitive Fellowship, Royal Colleges of Surgeons of Edinbugh and Ireland 2005)
    • 2nd place EANS Aesculap Prize for Neurosurgical Research (European Association of Neurosurgeons 2005)

    Untitled Document